TR199901450T2 - Helicobacter pylori canli asisi. - Google Patents

Helicobacter pylori canli asisi.

Info

Publication number
TR199901450T2
TR199901450T2 TR1999/01450T TR9901450T TR199901450T2 TR 199901450 T2 TR199901450 T2 TR 199901450T2 TR 1999/01450 T TR1999/01450 T TR 1999/01450T TR 9901450 T TR9901450 T TR 9901450T TR 199901450 T2 TR199901450 T2 TR 199901450T2
Authority
TR
Turkey
Prior art keywords
helicobacter pylori
canl
pylori
vaccines
infection
Prior art date
Application number
TR1999/01450T
Other languages
English (en)
Inventor
F. Meyer Thomas
Haas Rainer
Zhengxin Yan
Gomez-Duarte Oscar
Lucas Bernadette
Original Assignee
Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften
E.V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften, E.V filed Critical Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften
Publication of TR199901450T2 publication Critical patent/TR199901450T2/tr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/78Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Bu bulus, Helicobacter pylori tarafindan bir enfeksiyona karsi koruyucu bagisiklik temin eden yeni rekombinant canli asilara ve eniyilenmis asilar için H. pylori antigenlerinin taranmasi için bir yönteme iliskindir.
TR1999/01450T 1996-10-11 1997-09-01 Helicobacter pylori canli asisi. TR199901450T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96116337A EP0835928A1 (en) 1996-10-11 1996-10-11 Helicobacter pylori live vaccine

Publications (1)

Publication Number Publication Date
TR199901450T2 true TR199901450T2 (tr) 1999-10-21

Family

ID=8223286

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/01450T TR199901450T2 (tr) 1996-10-11 1997-09-01 Helicobacter pylori canli asisi.

Country Status (15)

Country Link
EP (2) EP0835928A1 (tr)
JP (1) JP2001510986A (tr)
KR (1) KR100510928B1 (tr)
CN (1) CN1215167C (tr)
AT (1) ATE392429T1 (tr)
AU (1) AU734635B2 (tr)
BR (1) BR9713254A (tr)
CA (1) CA2268033A1 (tr)
DE (1) DE69738641D1 (tr)
IL (1) IL129366A0 (tr)
NO (1) NO991692L (tr)
NZ (1) NZ335050A (tr)
PL (1) PL332575A1 (tr)
TR (1) TR199901450T2 (tr)
WO (1) WO1998016552A1 (tr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6248551B1 (en) * 1997-03-28 2001-06-19 Institut Pasteur Helicobacter aliphatic amidase AmiE polypeptides, and DNA sequences encoding those polypeptides
US6585975B1 (en) * 1998-04-30 2003-07-01 Acambis, Inc. Use of Salmonella vectors for vaccination against helicobacter infection
AU770498B2 (en) * 1998-06-19 2004-02-26 Merieux Oravax LT and CT in parenteral immunization methods against helicobacter infection
WO2000003730A1 (en) * 1998-07-16 2000-01-27 Cheil Jedang Corporation Urease based vaccine against helicobacter infection
EP1278768B1 (en) * 2000-04-27 2006-11-15 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Method for identifying helicobacter antigens
CA2821422C (en) * 2010-12-22 2024-01-02 Intervet International B.V. Vaccines comprising live aro mutant bordetella bronchiseptica
WO2012139137A2 (en) 2011-04-08 2012-10-11 Tufts Medical Center, Inc. Pepducin design and use
CA3005029A1 (en) 2015-11-13 2017-05-18 Oasis Pharmaceuticals, LLC Protease-activated receptor-2 modulators
CN112048008B (zh) * 2020-08-12 2021-06-15 河北医科大学第四医院(河北省肿瘤医院) 一种幽门螺杆菌b细胞耐受表位及其制备的抗体
CN112143741B (zh) * 2020-09-07 2022-09-20 中国科学院南海海洋研究所 一种生物膜基因岛GIVal43097及其切除方法
CN112190704B (zh) * 2020-10-13 2022-11-15 宁夏医科大学 M细胞靶向性重组乳酸菌疫苗及制备方法与应用
CN112143750B (zh) * 2020-10-13 2022-12-27 宁夏医科大学 靶向m细胞的重组乳酸菌表面展示系统、重组乳酸菌疫苗及制备方法与应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5695983A (en) * 1990-12-18 1997-12-09 The General Hospital Corporation Salmonella vaccines
DE4041045A1 (de) * 1990-12-20 1992-07-02 Max Planck Gesellschaft Zweiphasen-systeme fuer die produktion und praesentation von fremdantigen in hybriden lebendimpfstoffen
FR2682122B1 (fr) * 1991-10-03 1995-06-09 Pasteur Institut Nouveaux genes d'helicobacter pylori. leur utilisation pour la preparation de souches recombinantes de h. pylori.
US5348867A (en) * 1991-11-15 1994-09-20 George Georgiou Expression of proteins on bacterial surface
WO1995014093A1 (en) * 1993-05-19 1995-05-26 Institut Pasteur Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions and nucleic acid sequences encoding said polypeptides
EP0654273A1 (en) * 1993-11-18 1995-05-24 Harry H. Leveen Pharmaceutical product and method for treatment
WO1996026740A1 (en) * 1995-02-27 1996-09-06 Enteron Limited Partnership Methods and compositions for production of customized vaccines for diseases associated with antigens of microorganisms
HUP9801266A3 (en) * 1995-04-28 1999-07-28 Oravax Inc Cambridge Multimeric, recombinant urease vaccine

Also Published As

Publication number Publication date
KR100510928B1 (ko) 2005-08-31
NO991692L (no) 1999-06-04
KR20000049090A (ko) 2000-07-25
EP0931093B1 (en) 2008-04-16
EP0835928A1 (en) 1998-04-15
JP2001510986A (ja) 2001-08-07
EP0931093A1 (en) 1999-07-28
IL129366A0 (en) 2000-02-17
ATE392429T1 (de) 2008-05-15
AU734635B2 (en) 2001-06-21
PL332575A1 (en) 1999-09-27
BR9713254A (pt) 1999-11-03
DE69738641D1 (de) 2008-05-29
CN1215167C (zh) 2005-08-17
NO991692D0 (no) 1999-04-09
AU4208497A (en) 1998-05-11
CA2268033A1 (en) 1998-04-23
CN1246867A (zh) 2000-03-08
NZ335050A (en) 2000-08-25
WO1998016552A1 (en) 1998-04-23

Similar Documents

Publication Publication Date Title
TR199901450T2 (tr) Helicobacter pylori canli asisi.
DE69327534D1 (de) Impfstoffe gegen diphtherietoxin
NO880354L (no) Stoetsikker anordning for beskyttelse av styreenheter, spesielt fjernstyreenheter for tv.
DE68917157T2 (de) Einrichtung zur übertragung von energie.
DE69426051D1 (de) Infektiösen Bronchitis Virus 4/91 enthaltender Geflügel-Impfstoff
DK0707062T3 (da) Maltosephosphorylase, trehalosephosphorylase, plesiomonas stamme og fremgangsmåde til fremstilling af trehalose
NO910362D0 (no) Siloxancopolymerer som oppviser alkenylgrupper, fremgangsmaate for fremstilling av disse og anvendelse av disse.
DE69738512D1 (de) Epstein-barr virus type b ctl epitopen
DK0975360T3 (da) Bovint respiratorisk og enterisk coronavirus som vaccine
DK282384D0 (da) Malariaassocieret antigen, fremgangsmaade til fremstilling deraf og vaccine indeholdende antigenet
PT744027E (pt) Utilizacao de metodos para identificar oligopeptidos de sinal hidrofilicos
GB9818133D0 (en) Vaccine
IT8422159A0 (it) 16-fluoro-16,17-dideidro prostanoidi e procedimento per laloro preparazione.
BR9706813B1 (pt) bactéria transgênica, processo para a preparação de um polipeptìdeo e vacina.
EP0621790A4 (en) Attenuated, live vaccine for delaware strain ibdv.
IL88622A0 (en) Dna sequences which code for an antigenic protein,antigens coded for by said dna sequences and a vaccine and method for protecting birds using the same
DE69615537D1 (en) Helicobacter pylori antigen
NL300165I2 (nl) Babesiavaccin.
NZ316110A (en) vaccine containing an antigen from H. Influenzae and an antigen from influenza virus
MX9708226A (es) Vacunas que contienen una saponina y un esterol.
ATE100859T1 (de) Durch virusneutralisierende und schuetzende monokonale antikoerper erkanntes ibdv vp2 epitop.
NO941389L (no) Skjæreinnretning, f.eks. for skjæring av fjell
DK231590D0 (da) Klemme til sammenholdning af hjoerner mellem vaegdele af traadnetmateriale, f.eks. minkbure